Crohn's Disease and Colitis Trial, Not Yet Recruiting NCT07089771 Sponsor: Region Stockholm Condition: Crohn's Disease and Colitis
Back to Crohns Disease And Colitis

Crohn's Disease and Colitis Trial, Not Yet Recruiting

NCT07089771
Not Yet Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People aged 18 years or older who also meet at least one of the following conditions:
  • People who have extensive ulcerative colitis, indeterminate inflammatory bowel disease (IBD), or Crohn's disease affecting at least one-third of the colon, with a diagnosis history of at least 8 years
  • People who have IBD or indeterminate IBD along with a liver condition called primary sclerosing cholangitis (PSC)
  • People who have IBD or indeterminate IBD and have a parent, sibling, or child who has had bowel cancer

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who have previously had bowel cancer or have had surgery to remove all or part of the colon
  • People who have a medical reason why a dye used during the procedure cannot be safely used for them
  • People whose colonoscopy is being done for treatment purposes rather than surveillance or diagnosis
  • People who are pregnant
  • People who are not able to give their own informed consent to participate

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 30 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 0046703980931

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Not Applicable
Sponsor
Region Stockholm
Registry
ClinicalTrials.gov
Start date
1 May 2026
Est. completion
31 December 2029

Where this trial is recruiting

🇸🇪 Sweden

Primary endpoints

Proportion of patients with at least one dysplastic lesion detected during surveillance colonoscopy

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 30 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov